Market Place
Sourcing Support
Boehringer, Zealand`s Obesity Drug Resembles Novo`s Wegovy
29 Apr 2026 //
BIOSPACE
Profluent, Lilly Partner In $2.25B Genetic Medicine Deal
29 Apr 2026 //
REUTERS
Eli to buy Ajax Pharma for up to $2.3 billion in blood cancer
27 Apr 2026 //
REUTERS
Roche Backs Amylin Drug for Low-Side-Effect Obesity Care
23 Apr 2026 //
BIOSPACE
Lilly reneges on remainder of Rigel RIPK1 deal
22 Apr 2026 //
FIERCE BIOTECH
Eli to buy Boston`s Kelonia for up to $7 Billion in Cancer Push
21 Apr 2026 //
BIOSPACE
Lilly`s Foundayo pill lowers heart attack, stroke risk in study
16 Apr 2026 //
ENDPOINTS
Shed Expands Oral GLP-1 Access Nationwide With Foundayo
15 Apr 2026 //
PR NEWSWIRE
Lilly Buys ADC Specialist Crossbridge Bio In Vague $300M Deal
15 Apr 2026 //
FIERCE BIOTECH
Vasa Pharma Teams Up With Lilly Tunelab For Ai/Ml-Powered CAMKII
14 Apr 2026 //
PR NEWSWIRE
Lilly`s Jaypirca Boosts Progression-Free Survival In CLL/SLL
13 Apr 2026 //
PR NEWSWIRE
Retatrutide Ignites Buzz on Weight Loss, Longevity
13 Apr 2026 //
ECONOMICTIMES
Lilly`s weight-loss pill wins US approval
01 Apr 2026 //
REUTERS
Lilly, Baseline Explore GLP-1s for Addiction Treatment
30 Mar 2026 //
BIOSPACE
Lilly Embraces AI Biotech Insilico Again, Inking $2.75B Collab
29 Mar 2026 //
FIERCE BIOTECH
Lilly Taltz, Zepbound Show Strong PsA, Obesity Efficacy
28 Mar 2026 //
PR NEWSWIRE
Lilly EBGLYSS Shows 4-Year Control In Atopic Dermatitis
27 Mar 2026 //
PR NEWSWIRE
Apogee Data Drive Hype As Threat To Lilly, Sanofi Becomes Clear
23 Mar 2026 //
FIERCE BIOTECH
Gene Therapies For Hearing Loss Show Promise In Challenging Field
23 Mar 2026 //
BIOSPACE
Fauna Bio Reaches Obesity Target Milestone In Discovery Collab
20 Mar 2026 //
PHARMIWEB
Lilly`s Retatrutide Shows Promising Results In Type 2 Diabetes
19 Mar 2026 //
PR NEWSWIRE
Lilly Enhances Triple-G Agonist Profile In Late-Stage Diabetes
19 Mar 2026 //
BIOSPACE
Lilly-Backed Startup Raises $68.7M for Next-Gen T-Cell Therapy
18 Mar 2026 //
BIOSPACE
Lilly`s Ebglyss Scores Eczema Trial Win in Children
17 Mar 2026 //
FIERCE PHARMA
Lilly Pumps $3B Into China To Boost Supply Of Weight Loss Pill
12 Mar 2026 //
BIOSPACE
Lilly pledges $500M to South Korea biopharma industry
11 Mar 2026 //
FIERCE BIOTECH
North Carolina Attracts Amgen, Roche For Next-Gen Obesity Drug
03 Mar 2026 //
BIOSPACE
CHMP Recommends Lilly’s Olumiant for Teen Alopecia Areata in EU
27 Feb 2026 //
PR NEWSWIRE
Lilly`s Orforglipron Beats Semaglutide in Type 2 Diabetes Trial
26 Feb 2026 //
PR NEWSWIRE
Lilly Tops Novo In Weight Loss Again, This Time On The Oral Front
26 Feb 2026 //
BIOSPACE
Lilly to Launch Multi-Dose Weight-Loss Drug Device in US
24 Feb 2026 //
REUTERS
Lilly`s Taltz And Zepbound Show Superior Efficacy In Psoriasis
19 Feb 2026 //
PR NEWSWIRE
CSL Signs Licensing Deal with Eli Lilly for Clazakizumab
17 Feb 2026 //
REUTERS
Lilly`s Retevmo Delivers Substantial Event-Free Survival Benefit
16 Feb 2026 //
PR NEWSWIRE
Lilly Builds Sizable Store Of Orforglipron Ahead Of FDA Verdict
13 Feb 2026 //
FIERCE PHARMA
Eli Lilly Acquires $2.4B Orna For CAR T Entry In Autoimmune
09 Feb 2026 //
PR NEWSWIRE
Innovent And Lilly Partner To Develop Global Oncology
08 Feb 2026 //
PR NEWSWIRE
The Biggest Potential Drug Launches Of 2026
06 Feb 2026 //
FIERCE PHARMA
Lilly Eyes Pipeline in a Product as GLP-1s Move Into I&I
04 Feb 2026 //
BIOSPACE
Lilly Drops 3 Clinical Programs, Including Prevail Gene Therapy
04 Feb 2026 //
FIERCE BIOTECH
Repertoire, Lilly Partner on Autoimmune Diseases
29 Jan 2026 //
PR NEWSWIRE
Lilly Pens $1.1B Pact To Work On Hearing Loss Gene Editing Med
28 Jan 2026 //
PRESS RELEASE
FDA Grants Breakthrough Designation to Lilly`s Sofetabart
20 Jan 2026 //
PR NEWSWIRE
Recludix Pharma Secures Funds For Novel SH2 Domain Inhibitors
12 Jan 2026 //
GLOBENEWSWIRE
Bison Leads $33.5M Series B for Juvena`s Regenerative Pipeline
12 Jan 2026 //
BUSINESSWIRE
JPM26, Day 1: Updates From Lilly, Takeda, Novartis And Sofinnova
12 Jan 2026 //
FIERCE BIOTECH
Lilly, Nvidia form new AI co-innovation lab with $1B investment
12 Jan 2026 //
FIERCE BIOTECH
Abivax shares soar 23% as media report reignites M&A Chatters
11 Jan 2026 //
REUTERS
Chai Discovery Collaborates With Eli Lilly To Speed Up Biologics
09 Jan 2026 //
BUSINESSWIRE
Vida Ventures Applauds Aktis Oncology`s Public Market Debut
09 Jan 2026 //
BUSINESSWIRE
ProQR Announces AX-0810 Phase 1 Data and 2026 Candidate
08 Jan 2026 //
GLOBENEWSWIRE
Lilly touts Zepbound-Taltz combo in patients with obesity, PsA
08 Jan 2026 //
PR NEWSWIRE
BigHat Biosciences Partners With Eli Lilly on AI Biologics
07 Jan 2026 //
PHARMIWEB
Indupro Nabs 2nd Big Pharma Deal With $950M Lilly Pact
07 Jan 2026 //
BUSINESSWIRE
Lilly Acquires Ventyx Biosciences For Advancing Oral Therapies
07 Jan 2026 //
PR NEWSWIRE
Lilly in talks to buy Ventyx Biosciences for more than $1B
06 Jan 2026 //
REUTERS
MEDI&GENE Partners With Lilly To Advance Obesity Therapeutics
17 Dec 2025 //
PR NEWSWIRE
Lilly`s Inluriyo Shows Reinforced Efficacy in Breast Cancer
12 Dec 2025 //
PR NEWSWIRE
Lilly Shifts Oral SERD Hopes To Its Largest Oncology Trial Ever
12 Dec 2025 //
FIERCE PHARMA
Lilly`s obesity triple threat tops phase 3 efficacy forecasts
11 Dec 2025 //
PR NEWSWIRE
